NLRP3 and Parkinson disease: The development of Alzheimer’s Disease (AD), Parkinson’s Disease (PD) and Multiple Sclerosis (MS), through varying mechanisms, have been evidenced to prime and activate the NLRP3 inflammasome, which subsequently mediates further inflammation and damage.